Acadia Healthcare (NASDAQ:ACHC) Lowered to Sell Rating by StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday.

Other analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Barclays dropped their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Royal Bank of Canada decreased their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $79.67.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $38.23 on Friday. The firm has a market capitalization of $3.55 billion, a PE ratio of 12.53, a price-to-earnings-growth ratio of 1.71 and a beta of 1.33. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $87.77. The business’s 50-day moving average price is $54.15 and its 200-day moving average price is $64.55.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business earned $0.91 earnings per share. Sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds have recently made changes to their positions in the business. Point72 Asset Management L.P. boosted its holdings in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the period. Millennium Management LLC boosted its stake in shares of Acadia Healthcare by 3,067.8% during the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter. Holocene Advisors LP increased its position in shares of Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after buying an additional 649,997 shares during the period. Finally, William Blair Investment Management LLC raised its stake in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.